Cor Vasa 2025, 67(5):620-630 | DOI: 10.33678/cor.2025.064

(Non-Pharmacological Management of Ventricular Tachycardias in a Complex Cardiovascular Center)

Filip Schlossera, b, Petr Peichla, Josef Kautznera
a Klinika kardiologie, Institut klinické a experimentální medicíny, Praha, Česká republika
b 3. lékařská fakulta Univerzity Karlovy v Praze, Praha, Česká republika

Ventricular arrhythmias significantly influence morbidity and mortality in patients with structural heart dis- ease. Implantable cardioverter-defibrillators positively affect survival but do not prevent ventricular arrhythmias. Until recently, the cornerstone of management of ventricular arrhythmias was administration of antiarrhythmic drugs, which have limited efficacy and non-negligible side effects. Nowadays, newer non-pharmacological treatment modalities have emerged, namely catheter ablation. Radiofrequency energy is considered the gold standard and its effect can be further augmented by using different types of catheters, alternative perfusion agents, or modified ablation techniques. Alternatively, cryoablation or pulse field ablation make a promise for the future as pulse field ablation has already become an established treatment strategy for managing atrial fibrillation. Additionally, alcohol ablation by administering concentrated ethanol into coronary arteries or veins subtending blood flow to the arrhythmogenic substrate may be used in a selected population. Newer non-invasive treatment method is stereotactic arrhythmia radiotherapy, especially for patients after catheter ablation failure. The aim of this review is to summarize up-to-date non-pharmacological treatment options for ventricular tachycardias.

Keywords: Alcohol ablation, Catheter ablation, Cryoablation, Pulsed field ablation, Stereotactic arrhythmia radiotherapy, Ventricular tachycardia

Received: March 29, 2025; Revised: March 29, 2025; Accepted: May 1, 2025; Prepublished online: June 2, 2012; Published: November 6, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Schlosser F, Peichl P, Kautzner J. (Non-Pharmacological Management of Ventricular Tachycardias in a Complex Cardiovascular Center). Cor Vasa. 2025;67(5):620-630. doi: 10.33678/cor.2025.064.
Download citation

References

  1. Zeppenfeld K, Tfelt-Hansen J, de Riva M, et al. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Developed by the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC) Endorsed by the Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J 2022;43:3997-4126. Go to original source... Go to PubMed...
  2. Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. Circulation 2018;138:e272-e391.
  3. Lenarczyk R, Zeppenfeld K, Tfelt-Hansen J, et al. Management of patients with an electrical storm or clustered ventricular arrhythmias: a clinical consensus statement of the European Heart Rhythm Association of the ESC - endorsed by the Asia-Pacific Heart Rhythm Society, Heart Rhythm Society, and Latin-American Heart Rhythm Society. EP Europace 2024;26:euae049. Go to original source... Go to PubMed...
  4. Packer DL, Prutkin JM, Hellkamp AS, et al. Impact of Implantable Cardioverter-Defibrillator, Amiodarone, and Placebo on the Mode of Death in Stable Patients With Heart Failure. Circulation 2009;120:2170-2176. Go to original source... Go to PubMed...
  5. Connolly SJ, Hallstrom AP, Cappato R, et al. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. Eur Heart J 2000;21:2071-2078. Go to original source... Go to PubMed...
  6. Cappato R. Secondary prevention of sudden death: the Dutch study, the antiarrhythmics versus implantable defibrillator trial, the cardiac arrest study Hamburg, and the Canadian implantable defibrillator study. Am J Cardiol 1999;83(Suppl. 2):68-73. Go to original source... Go to PubMed...
  7. Moss AJ, Greenberg H, Case RB, et al. Long-Term Clinical Course of Patients After Termination of Ventricular Tachyarrhythmia by an Implanted Defibrillator. Circulation 2004;110:3760-3765. Go to original source... Go to PubMed...
  8. Bianchi S, Cauti FM. Ablation of ventricular tachycardia in 2021. Eur Heart J Suppl 2021;23(Supplement_E):E25-E27. Go to original source... Go to PubMed...
  9. Betensky BP, Marchlinski FE. Outcomes of Catheter Ablation of Ventricular Tachycardia in the Setting of Structural Heart Disease. Curr Cardiol Rep 2016;18:68. Go to original source... Go to PubMed...
  10. Dukkipati SR, Koruth JS, Choudry S, et al. Catheter Ablation of Ventricular Tachycardia in Structural Heart Disease. J Am Coll Cardiol 2017;70:2924-2941. Go to original source... Go to PubMed...
  11. Zeppenfeld K. Ventricular Tachycardia Ablation in Nonischemic Cardiomyopathy. JACC: Clin Electrophysiol 2018;4:1123-1140. Go to original source... Go to PubMed...
  12. Guandalini GS, Liang JJ, Marchlinski FE. Ventricular Tachycardia Ablation. JACC: Clin Electrophysiol 2019;5:1363-1383. Go to original source... Go to PubMed...
  13. Sapp JL, Tang ASL, Parkash R, et al. Catheter Ablation or Antiarrhythmic Drugs for Ventricular Tachycardia. N Engl J Med 2025;392:737-747. Go to original source... Go to PubMed...
  14. Dixit S, Callans DJ. Role of contact and noncontact mapping in the curative ablation of tachyarrhythmias. Curr Opin Cardiol 2002;17:65-72. Go to original source... Go to PubMed...
  15. Zeppenfeld K, Stevenson WG. Ablation of Ventricular Tachycardia in Patients with Structural Heart Disease. Pacing Clin Electrophysiol 2008;31:358-374. Go to original source... Go to PubMed...
  16. Bourier F, Martin R, Martin CA, et al. Is it feasible to offer 'targeted ablation' of ventricular tachycardia circuits with better understanding of isthmus anatomy and conduction characteristics? EP Europace 2019;21(Suppl. 1):i27-i33.
  17. Hongo RH. Catheter Ablation of Scar-mediated Ventricular Tachycardia: Are Substrate-based Approaches Replacing Mapping? J Innov Card Rhythm Manag 2019;10:3707-3715. Go to original source... Go to PubMed...
  18. Mariani S, Napp LC, Kraaier K, et al. Prophylactic mechanical circulatory support for protected ventricular tachycardia ablation: A meta-analysis of the literature. Artif Organs 2021;45:987-997. Go to original source... Go to PubMed...
  19. Kautzner J, Hašková J, Stojadinovič P, et al. Percutaneous mechanical support in catheter ablation of ventricular arrhythmias: hype or hope? EP Europace 2024;26:euae186. Go to original source... Go to PubMed...
  20. Yokokawa M, Kim HM, Baser K, et al. Predictive Value of Programmed Ventricular Stimulation After Catheter Ablation of Post-Infarction Ventricular Tachycardia. J Am Coll Cardiol 2015;65:1954-1959. Go to original source... Go to PubMed...
  21. Di Biase L, Burkhardt JD, Lakkireddy D, et al. Ablation of Stable VTs Versus Substrate Ablation in Ischemic Cardiomyopathy: The VISTA Randomized Multicenter Trial. J Am Coll Cardiol 2015;66:2872-2882. Go to original source...
  22. Briceño DF, Romero J, Villablanca PA, et al. Long-term outcomes of different ablation strategies for ventricular tachycardia in patients with structural heart disease: systematic review and meta-analysis. EP Europace 2018;20:104-115. Go to original source... Go to PubMed...
  23. Piers SRD, Tao Q, van Huls van Taxis CFB, et al. Contrast-Enhanced MRI-Derived Scar Patterns and Associated Ventricular Tachycardias in Nonischemic Cardiomyopathy. Circ Arrhythm Electrophysiol 2013;6:875-883. Go to original source... Go to PubMed...
  24. Oloriz T, Silberbauer J, Maccabelli G, et al. Catheter Ablation of Ventricular Arrhythmia in Nonischemic Cardiomyopathy. Circ Arrhythm Electrophysiol 2014;7:414-423. Go to original source... Go to PubMed...
  25. Proietti R, Essebag V, Beardsall J, et al. Substrate-guided ablation of haemodynamically tolerated and untolerated ventricular tachycardia in patients with structural heart disease: effect of cardiomyopathy type and acute success on long-term outcome. EP Europace 2015;17:461-467. Go to original source... Go to PubMed...
  26. Vaseghi M, Hu TY, Tung R, et al. Outcomes of Catheter Ablation of Ventricular Tachycardia Based on Etiology in Nonischemic Heart Disease: An International Ventricular Tachycardia Ablation Center Collaborative Study. JACC Clin Electrophysiol 2018;4:1141-1150. Go to original source... Go to PubMed...
  27. Garcia FC, Bazan V, Zado ES, et al. Epicardial Substrate and Outcome With Epicardial Ablation of Ventricular Tachycardia in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia. Circulation 2009;120:366-375. Go to original source...
  28. Sosa E, Scanavacca M, D'avila A, et al. Endocardial and Epicardial Ablation Guided by Nonsurgical Transthoracic Epicardial Mapping to Treat Recurrent Ventricular Tachycardia. J Cardiovasc Electrophysiol 1998;9:229-239. Go to original source... Go to PubMed...
  29. Soejima K, Couper G, Cooper JM, et al. Subxiphoid Surgical Approach for Epicardial Catheter-Based Mapping and Ablation in Patients With Prior Cardiac Surgery or Difficult Pericardial Access. Circulation 2004;110:1197-1201. Go to original source... Go to PubMed...
  30. Klein LS, Shih HT, Hackett FK, et al. Radiofrequency catheter ablation of ventricular tachycardia in patients without structural heart disease. Circulation 1992;85:1666-1674. Go to original source... Go to PubMed...
  31. Morady F, Harvey M, Kalbfleisch SJ, et al. Radiofrequency catheter ablation of ventricular tachycardia in patients with coronary artery disease. Circulation 1993;87:363-372. Go to original source...
  32. Haines D. Biophysics of Ablation. J Cardiovasc Electrophysiol 2004;15(s10):S2-S11. Go to original source...
  33. Haines DE, Whayne JG, Walker J, et al. The Effect of Radiofrequency Catheter Ablation on Myocardial Creatine Kinase Activity. J Cardiovasc Electrophysiol 1995;6:79-88. Go to original source... Go to PubMed...
  34. Wood MA, Fuller IA. Acute and Chronic Electrophysiologic Changes Surrounding Radiofrequency Lesions. J Cardiovasc Electrophysiol 2002;13:56-61. Go to original source... Go to PubMed...
  35. Wright M, Harks E, Deladi S, et al. Visualizing Intramyocardial Steam Formation with a Radiofrequency Ablation Catheter Incorporating Near-Field Ultrasound. J Cardiovasc Electrophysiol 2013;24:1403-1409. Go to original source... Go to PubMed...
  36. Stevenson WG, Sapp JL. Newer Methods for Ventricular Tachycardia Ablation and When to Use Them. Can J Cardiol 2022;38:502-514. Go to original source... Go to PubMed...
  37. Barkagan M, Leshem E, Shapira-Daniels A, et al. Histopathological Characterization of Radiofrequency Ablation in Ventricular Scar Tissue. JACC Clin Electrophysiol 2019;5:920-931. Go to original source... Go to PubMed...
  38. Pérez JJ, D'avila A, Aryana A, et al. Can Fat Deposition After Myocardial Infarction Alter the Performance of RF Catheter Ablation of Scar-Related Ventricular Tachycardia?: Results from a Computer Modeling Study. J Cardiovasc Electrophysiology 2016;27:947-952. Go to original source... Go to PubMed...
  39. Marchlinski FE, Haffajee CI, Beshai JF, et al. Long-Term Success of Irrigated Radiofrequency Catheter Ablation of Sustained Ventricular Tachycardia: Post-Approval THERMOCOOL VT Trial. J Am Coll Cardiol 2016;67:674-683. Go to original source... Go to PubMed...
  40. Nguyen DT, Olson M, Zheng L, et al. Effect of Irrigant Characteristics on Lesion Formation After Radiofrequency Energy Delivery Using Ablation Catheters with Actively Cooled Tips. J Cardiovasc Electrophysiol 2015;26:792-798. Go to original source... Go to PubMed...
  41. Shapira-Daniels A, Barkagan M, Rottmann M, et al. Modulating the Baseline Impedance. Circ Arrhythm Electrophysiol 2019;12:e007336. Go to original source... Go to PubMed...
  42. Koruth JS, Iwasawa J, Enomoto Y, et al. Chamber-Specific Radiofrequency Lesion Dimension Estimation Using Novel Catheter-Based Tissue Interface Temperature Sensing: A Preclinical Assessment. JACC Clin Electrophysiol 2017;3:1092-1102. Go to original source... Go to PubMed...
  43. Della Bella P, Peretto G, Paglino G, et al. Bipolar radiofrequency ablation for ventricular tachycardias originating from the interventricular septum: Safety and efficacy in a pilot cohort study. Heart Rhythm 2020;17:2111-2118. Go to original source... Go to PubMed...
  44. Sauer PJ, Kunkel MJ, Nguyen DT, et al. Successful ablation of ventricular tachycardia arising from a midmyocardial septal outflow tract site utilizing a simplified bipolar ablation setup. HeartRhythm Case Rep 2019;5:105-108. Go to original source... Go to PubMed...
  45. González-Suárez A, Trujillo M, Koruth J, et al. Radiofrequency cardiac ablation with catheters placed on opposing sides of the ventricular wall: Computer modelling comparing bipolar and unipolar modes. Int J Hyperthermia 2014;30:372-384. Go to original source... Go to PubMed...
  46. Soucek F, Caluori G, Lehar F, et al. Bipolar ablation with contact force-sensing of swine ventricles shows improved acute lesion features compared to sequential unipolar ablation. J Cardiovasc Electrophysiol 2020;31:1128-1136. Go to original source... Go to PubMed...
  47. Nguyen DT, Zheng L, Zipse MM, et al. Bipolar radiofrequency ablation creates different lesion characteristics compared to simultaneous unipolar ablation. J Cardiovasc Electrophysiol 2019;30:2960-2967. Go to original source... Go to PubMed...
  48. Yamada T, Maddox WR, McElderry HT, et al. Radiofrequency Catheter Ablation of Idiopathic Ventricular Arrhythmias Originating From Intramural Foci in the Left Ventricular Outflow Tract. Circ Arrhythm Electrophysiol 2015;8:344-352. Go to original source... Go to PubMed...
  49. Yang J, Liang J, Shirai Y, et al. Outcomes of simultaneous unipolar radiofrequency catheter ablation for intramural septal ventricular tachycardia in nonischemic cardiomyopathy. Heart Rhythm 2019;16:863-870. Go to original source... Go to PubMed...
  50. Sapp JL, Cooper JM, Zei P, Stevenson WG. Large Radiofrequency Ablation Lesions Can Be Created with a Retractable Infusion-Needle Catheter. J Cardiovasc Electrophysiol 2006;17:657-661. Go to original source... Go to PubMed...
  51. Berte B, Cochet H, Magat J, et al. Irrigated Needle Ablation Creates Larger and More Transmural Ventricular Lesions Compared With Standard Unipolar Ablation in an Ovine Model. Circ Arrhythm Electrophysiol 2015;8:1498-1506. Go to original source...
  52. Sapp JL, Beeckler C, Pike R, et al. Initial Human Feasibility of Infusion Needle Catheter Ablation for Refractory Ventricular Tachycardia. Circulation 2013;128:2289-2295. Go to original source... Go to PubMed...
  53. Packer DL, Wilber DJ, Kapa S, et al. Ablation of Refractory Ventricular Tachycardia Using Intramyocardial Needle Delivered Heated Saline-Enhanced Radiofrequency Energy: A First-in-Man Feasibility Trial. Circ Arrhythm Electrophysiol 2022;15:e010347. Go to original source...
  54. Andrade JG, Wazni OM, Kuniss M, et al. Cryoballoon Ablation as Initial Treatment for Atrial Fibrillation: JACC State-of-the-Art Review. J Am Coll Cardiol 2021;78:914-930. Go to original source... Go to PubMed...
  55. Budman H, Shitzer A, Dayan J. Analysis of the Inverse Problem of Freezing and Thawing of a Binary Solution During Cryosurgical Processes. J Biomech Eng 1995;117:193-202. Go to original source...
  56. Mazur P. Cryobiology: The Freezing of Biological Systems. Science 1970;168:939-949. Go to original source... Go to PubMed...
  57. Meryman HT. Mechanics of Freezing in Living Cells and Tissues. Science 1956;124:515-521. Go to original source... Go to PubMed...
  58. Gage AA, Guest K, Montes M, et al. Effect of varying freezing and thawing rates in experimental cryosurgery. Cryobiology 1985;22:175-182. Go to original source... Go to PubMed...
  59. Baust J, Gage AA, Ma H, Zhang CM. Minimally Invasive Cryosurgery - Technological Advances. Cryobiology 1997;34:373-384. Go to original source... Go to PubMed...
  60. Khairy P, Chauvet P, Lehmann J, et al. Lower Incidence of Thrombus Formation With Cryoenergy Versus Radiofrequency Catheter Ablation. Circulation 2003;107:2045-2050. Go to original source... Go to PubMed...
  61. Berte B, Sacher F, Wielandts JY, et al. A new cryoenergy for ventricular tachycardia ablation: a proof-of-concept study. EP Europace 2017;19:1401-1407. Go to original source... Go to PubMed...
  62. Gordon JP, Liang JJ, Pathak RK, et al. Percutaneous cryoablation for papillary muscle ventricular arrhythmias after failed radiofrequency catheter ablation. J Cardiovasc Electrophysiol 2018;29:1654-1663. Go to original source... Go to PubMed...
  63. Chinitz JS, Sedaghat D, Harding M, et al. Adjuvant use of a cryoballoon to facilitate ablation of premature ventricular contraction-triggered ventricular fibrillation originating from the moderator band. HeartRhythm Case Rep 2019;5:578-581. Go to original source... Go to PubMed...
  64. De Potter T, Balt JC, Boersma L, et al. First-in-Human Experience With Ultra-Low Temperature Cryoablation for Monomorphic Ventricular Tachycardia. JACC Clin Electrophysiol 2023;9:686-691. Go to original source... Go to PubMed...
  65. Anter E, Hutchinson MD, Deo R, et al. Surgical Ablation of Refractory Ventricular Tachycardia in Patients With Nonischemic Cardiomyopathy. Circ Arrhythm Electrophysiol 2011;4:494-500. Go to original source... Go to PubMed...
  66. Jauregui-Abularach ME, Campos B, Betensky BP, et al. Comparison of Epicardial Cryoablation and Irrigated Radiofrequency Ablation in a Swine Infarct Model. J Cardiovasc Electrophysiol 2012;23:1016-1023. Go to original source... Go to PubMed...
  67. Reek S, Geller JC, Schildhaus HU, et al. Feasibility of Catheter Cryoablation in Normal Ventricular Myocardium and Healed Myocardial Infarction. Pacing Clin Electrophysiol 2004;27:1530-1539. Go to original source... Go to PubMed...
  68. Liuba I, Younis A, Sperling J, et al. Efficacy of balloon-expandable extreme-low-temperature ventricular epicardial cryoablation: A preclinical proof of concept evaluation. Heart Rhythm 2025;22:e183-e191. Go to original source... Go to PubMed...
  69. Stewart MT, Haines DE, Verma A, et al. Intracardiac pulsed field ablation: Proof of feasibility in a chronic porcine model. Heart Rhythm 2019;16:754-764. Go to original source... Go to PubMed...
  70. Kotnik T, Rems L, Tarek M, Miklavčič D. Membrane Electroporation and Electropermeabilization: Mechanisms and Models. Annu Rev Biophys 2019;48:63-91. Go to original source... Go to PubMed...
  71. van Driel VJHM, Neven KGEJ, van Wessel H, et al. Pulmonary Vein Stenosis After Catheter Ablation. Circ Arrhythm Electrophysiol 2014;7:734-738. Go to original source...
  72. van Driel VJHM, Neven K, van Wessel H, et al. Low vulnerability of the right phrenic nerve to electroporation ablation. Heart Rhythm 2015;12:1838-1844. Go to original source... Go to PubMed...
  73. Koruth J, Kuroki K, Iwasawa J, et al. Preclinical Evaluation of Pulsed Field Ablation. Circ Arrhythm Electrophysiol 2019;12:e007781. Go to original source... Go to PubMed...
  74. Yavin H, Shapira-Daniels A, Barkagan M, et al. Pulsed Field Ablation Using a Lattice Electrode for Focal Energy Delivery. Circ Arrhythm Electrophysiol 2020;13:e008580. Go to original source... Go to PubMed...
  75. Howard B, Haines DE, Verma A, et al. Characterization of Phrenic Nerve Response to Pulsed Field Ablation. Circ Arrhythm Electrophysiol 2022;15:e010127. Go to original source... Go to PubMed...
  76. Turagam MK, Neuzil P, Schmidt B, et al. Safety and Effectiveness of Pulsed Field Ablation to Treat Atrial Fibrillation: One-Year Outcomes From the MANIFEST-PF Registry. Circulation 2023;148:35-46. Go to original source...
  77. Reddy VY, Petru J, Funasako M, et al. Coronary Arterial Spasm During Pulsed Field Ablation to Treat Atrial Fibrillation. Circulation 2022;146:1808-1819. Go to original source... Go to PubMed...
  78. Wittkampf FHM, van Driel VJ, van Wessel H, et al. Myocardial Lesion Depth With Circular Electroporation Ablation. Circ Arrhythm Electrophysiol 2012;5:581-586. Go to original source... Go to PubMed...
  79. Neven K, van Driel V, van Wessel H, et al. Myocardial Lesion Size After Epicardial Electroporation Catheter Ablation After Subxiphoid Puncture. Circ Arrhythm Electrophysiol 2014;7:728-733. Go to original source... Go to PubMed...
  80. Koruth JS, Kuroki K, Iwasawa J, et al. Endocardial ventricular pulsed field ablation: a proof-of-concept preclinical evaluation. EP Europace 2020;22:434-439. Go to original source... Go to PubMed...
  81. Kawamura I, Reddy VY, Wang BJ, et al. Pulsed Field Ablation of the Porcine Ventricle Using a Focal Lattice-Tip Catheter. Circ Arrhythm Electrophysiol 2022;15:e011120. Go to original source... Go to PubMed...
  82. Im SI, Higuchi S, Lee A, et al. Pulsed Field Ablation of Left Ventricular Myocardium in a Swine Infarct Model. JACC: Clin Electrophysiol 2022;8:722-731. Go to original source... Go to PubMed...
  83. Peichl P, Bulava A, Wichterle D, et al. Efficacy and safety of focal pulsed-field ablation for ventricular arrhythmias: two-centre experience. EP Europace 2024;26:euae192. Go to original source... Go to PubMed...
  84. Peichl P, Wichterle D, Schlosser F, et al. Mapping and ablation of ventricular tachycardia using dual-energy lattice-tip focal catheter: early feasibility and safety study. EP Europace 2024;26:euae275. Go to original source... Go to PubMed...
  85. Schurmann P, Peñalver J, Valderrábano M. Ethanol for the treatment of cardiac arrhythmias. Curr Opin Cardiol 2015;30:333-343. Go to original source... Go to PubMed...
  86. Reek S, Geller JC, Schildhaus HU, et al. Catheter Ablation of Ventricular Tachycardia by Intramyocardial Injection of Ethanol in an Animal Model of Chronic Myocardial Infarction. J Cardiovasc Electrophysiol 2004;15:332-341. Go to original source... Go to PubMed...
  87. Verna E, Repetto S, Savari C, et al. Myocardial dissection following successful chemical ablation of ventricular tachycardia. Eur Heart J 1992;13:844-846. Go to original source... Go to PubMed...
  88. Inoue H, Waller BF, Zipes DP. Intracoronary ethyl alcohol or phenol injection ablates aconitine-induced ventricular tachycardia in dogs. J Am Coll Cardiol 1987;10:1342-1349. Go to original source... Go to PubMed...
  89. Brugada P, de Swart H, Smeets JLRM, et al. Termination of tachycardias by interrupting blood flow to the arrhythmogenic area. Am J Cardiol 1988;62:387-392. Go to original source... Go to PubMed...
  90. Brugada P, de Swart H, Smeets JL, Wellens HJ. Transcoronary chemical ablation of ventricular tachycardia. Circulation 1989;79:475-482. Go to original source... Go to PubMed...
  91. Tokuda M, Sobieszczyk P, Eisenhauer AC, et al. Transcoronary Ethanol Ablation for Recurrent Ventricular Tachycardia After Failed Catheter Ablation. Circ Arrhythm Electrophysiol 2011;4:889-896. Go to original source... Go to PubMed...
  92. Baher A, Shah DJ, Valderrabano M. Coronary venous ethanol infusion for the treatment of refractory ventricular tachycardia. Heart Rhythm 2012;9:1637-1639. Go to original source... Go to PubMed...
  93. Kreidieh B, Rodríguez-Mañero M, A. Schurmann P, et al. Retrograde Coronary Venous Ethanol Infusion for Ablation of Refractory Ventricular Tachycardia. Circ Arrhythm Electrophysiol 2016;9:e004352. Go to original source... Go to PubMed...
  94. Tavares L, Lador A, Fuentes S, et al. Intramural Venous Ethanol Infusion for Refractory Ventricular Arrhythmias: Outcomes of a Multicenter Experience. JACC Clin Electrophysiol 2020;6:1420-1431. Go to original source... Go to PubMed...
  95. Creta A, Earley MJ, Schilling RJ, et al. Ethanol ablation for ventricular arrhythmias: A systematic review and meta-analysis. J Cardiovasc Electrophysiol 2022;33:510-526. Go to original source... Go to PubMed...
  96. Sharma A, Wong D, Weidlich G, et al. Noninvasive stereotactic radiosurgery (CyberHeart) for creation of ablation lesions in the atrium. Heart Rhythm 2010;7:802-810. Go to original source... Go to PubMed...
  97. Lehmann HI, Deisher AJ, Takami M, et al. External Arrhythmia Ablation Using Photon Beams. Circ Arrhythm Electrophysiol 2017;10:e004304. Go to original source... Go to PubMed...
  98. Blanck O, Bode F, Gebhard M, et al. Dose-Escalation Study for Cardiac Radiosurgery in a Porcine Model. Int J Radiat Oncol Biol Phys 2014;89:590-598. Go to original source... Go to PubMed...
  99. Jumeau R, Ozsahin M, Schwitter J, et al. Rescue procedure for an electrical storm using robotic non-invasive cardiac radio-ablation. Radiother Oncol 2018;128:189-191. Go to original source... Go to PubMed...
  100. Cuculich PS, Schill MR, Kashani R, et al. Noninvasive Cardiac Radiation for Ablation of Ventricular Tachycardia. N Engl J Med 2017;377:2325-2336. Go to original source... Go to PubMed...
  101. Zhang DM, Navara R, Yin T, et al. Cardiac radiotherapy induces electrical conduction reprogramming in the absence of transmural fibrosis. Nat Commun 2021;12:5558. Go to original source... Go to PubMed...
  102. Hašková J, Wichterle D, Kautzner J, et al. Efficacy and Safety of Stereotactic Radiotherapy in Patients With Recurrent Ventricular Tachycardias: The Czech Experience. JACC Clin Electrophysiol 2024;10:654-666. Go to original source...
  103. Cvek J, Neuwirth R, Knybel L, et al. Cardiac Radiosurgery for Malignant Ventricular Tachycardia. Cureus 2014;6(7). Go to original source...
  104. Loo BW, Soltys SG, Wang L, et al. Stereotactic Ablative Radiotherapy for the Treatment of Refractory Cardiac Ventricular Arrhythmia. Circ Arrhythm Electrophysiol 2015;8:748-750. Go to original source... Go to PubMed...
  105. Neuwirth R, Cvek J, Knybel L, et al. Stereotactic radiosurgery for ablation of ventricular tachycardia. EP Europace 2019;21:1088-1095. Go to original source...
  106. Lloyd MS, Wight J, Schneider F, et al. Clinical experience of stereotactic body radiation for refractory ventricular tachycardia in advanced heart failure patients. Heart Rhythm 2020;17:415-422. Go to original source... Go to PubMed...
  107. Gianni C, Rivera D, Burkhardt JD, et al. Stereotactic arrhythmia radioablation for refractory scar-related ventricular tachycardia. Heart Rhythm 2020;17:1241-1248. Go to original source... Go to PubMed...
  108. Chin R, Hayase J, Hu P, et al. Non-invasive stereotactic body radiation therapy for refractory ventricular arrhythmias: an institutional experience. J Interv Card Electrophysiol 2021;61:535-543. Go to original source... Go to PubMed...
  109. Carbucicchio C, Andreini D, Piperno G, et al. Stereotactic radioablation for the treatment of ventricular tachycardia: preliminary data and insights from the STRA-MI-VT phase Ib/II study. J Interv Card Electrophysiol 2021;62:427-439. Go to original source... Go to PubMed...
  110. Qian PC, Quadros K, Aguilar M, et al. Substrate Modification Using Stereotactic Radioablation to Treat Refractory Ventricular Tachycardia in Patients With Ischemic Cardiomyopathy. JACC Clin Electrophysiol 2022;8:49-58. Go to original source...
  111. Haskova J, Peichl P, Pirk J, et al. Stereotactic radiosurgery as a treatment for recurrent ventricular tachycardia associated with cardiac fibroma. HeartRhythm Case Rep 2019;5:44-47. Go to original source... Go to PubMed...
  112. Robinson CG, Samson PP, Moore KMS, et al. Phase I/II Trial of Electrophysiology-Guided Noninvasive Cardiac Radioablation for Ventricular Tachycardia. Circulation 2019;139:313-321. Go to original source... Go to PubMed...

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.